Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
1.0 |
High Similarity |
NPD283 |
Approved |
0.9857 |
High Similarity |
NPD242 |
Approved |
0.9857 |
High Similarity |
NPD338 |
Approved |
0.9787 |
High Similarity |
NPD339 |
Approved |
0.9718 |
High Similarity |
NPD169 |
Phase 2 |
0.9565 |
High Similarity |
NPD249 |
Approved |
0.9565 |
High Similarity |
NPD250 |
Approved |
0.9429 |
High Similarity |
NPD186 |
Discovery |
0.9429 |
High Similarity |
NPD195 |
Approved |
0.9143 |
High Similarity |
NPD185 |
Approved |
0.9041 |
High Similarity |
NPD3107 |
Discontinued |
0.9041 |
High Similarity |
NPD1369 |
Phase 2 |
0.9041 |
High Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.9014 |
High Similarity |
NPD166 |
Approved |
0.9 |
High Similarity |
NPD193 |
Suspended |
0.8947 |
High Similarity |
NPD247 |
Clinical (unspecified phase) |
0.8859 |
High Similarity |
NPD2624 |
Phase 2 |
0.8859 |
High Similarity |
NPD2646 |
Discontinued |
0.8859 |
High Similarity |
NPD1732 |
Phase 3 |
0.8824 |
High Similarity |
NPD7988 |
Suspended |
0.879 |
High Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.8734 |
High Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.8639 |
High Similarity |
NPD548 |
Clinical (unspecified phase) |
0.8627 |
High Similarity |
NPD3083 |
Approved |
0.8625 |
High Similarity |
NPD4716 |
Approved |
0.8609 |
High Similarity |
NPD218 |
Approved |
0.8609 |
High Similarity |
NPD220 |
Clinical (unspecified phase) |
0.8609 |
High Similarity |
NPD219 |
Phase 3 |
0.8609 |
High Similarity |
NPD216 |
Approved |
0.8609 |
High Similarity |
NPD217 |
Approved |
0.8571 |
High Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.8411 |
Intermediate Similarity |
NPD214 |
Approved |
0.8411 |
Intermediate Similarity |
NPD213 |
Clinical (unspecified phase) |
0.8408 |
Intermediate Similarity |
NPD2647 |
Phase 3 |
0.8364 |
Intermediate Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD2630 |
Approved |
0.8263 |
Intermediate Similarity |
NPD2632 |
Approved |
0.8227 |
Intermediate Similarity |
NPD248 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD9633 |
Phase 3 |
0.8148 |
Intermediate Similarity |
NPD5666 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD546 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD7158 |
Phase 1 |
0.8099 |
Intermediate Similarity |
NPD9632 |
Phase 3 |
0.8071 |
Intermediate Similarity |
NPD9408 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD1777 |
Approved |
0.8 |
Intermediate Similarity |
NPD1776 |
Approved |
0.7958 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD252 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD3085 |
Phase 1 |
0.7848 |
Intermediate Similarity |
NPD4074 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD1692 |
Approved |
0.7806 |
Intermediate Similarity |
NPD3086 |
Phase 3 |
0.775 |
Intermediate Similarity |
NPD516 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD549 |
Approved |
0.7719 |
Intermediate Similarity |
NPD5682 |
Phase 3 |
0.7719 |
Intermediate Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD194 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD3695 |
Approved |
0.7616 |
Intermediate Similarity |
NPD3696 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4054 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD536 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD582 |
Approved |
0.7308 |
Intermediate Similarity |
NPD171 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD3708 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7138 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD353 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD4240 |
Approved |
0.7216 |
Intermediate Similarity |
NPD1063 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD231 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD2876 |
Phase 3 |
0.7021 |
Intermediate Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD9605 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD9606 |
Approved |
0.6947 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD9607 |
Approved |
0.6875 |
Remote Similarity |
NPD1046 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.6804 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.6804 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD9409 |
Discontinued |
0.671 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.6701 |
Remote Similarity |
NPD4495 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD6840 |
Approved |
0.6644 |
Remote Similarity |
NPD9374 |
Approved |
0.6628 |
Remote Similarity |
NPD527 |
Clinical (unspecified phase) |
0.6626 |
Remote Similarity |
NPD1730 |
Discontinued |
0.6621 |
Remote Similarity |
NPD9373 |
Approved |
0.6603 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.6579 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.6577 |
Remote Similarity |
NPD307 |
Approved |
0.6538 |
Remote Similarity |
NPD282 |
Approved |
0.6519 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.6446 |
Remote Similarity |
NPD775 |
Approved |
0.6398 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.638 |
Remote Similarity |
NPD1430 |
Approved |
0.638 |
Remote Similarity |
NPD2253 |
Discontinued |
0.638 |
Remote Similarity |
NPD1431 |
Approved |
0.6369 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.6352 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.6352 |
Remote Similarity |
NPD1058 |
Discontinued |
0.631 |
Remote Similarity |
NPD207 |
Discontinued |
0.6309 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.6289 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.6289 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.6287 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD8836 |
Approved |
0.6242 |
Remote Similarity |
NPD1128 |
Approved |
0.6242 |
Remote Similarity |
NPD1127 |
Approved |
0.6218 |
Remote Similarity |
NPD281 |
Approved |
0.6196 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6196 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6135 |
Remote Similarity |
NPD6112 |
Approved |
0.6122 |
Remote Similarity |
NPD9416 |
Phase 3 |
0.6122 |
Remote Similarity |
NPD9417 |
Phase 3 |
0.6121 |
Remote Similarity |
NPD1118 |
Discontinued |
0.6107 |
Remote Similarity |
NPD9375 |
Discontinued |
0.609 |
Remote Similarity |
NPD798 |
Discontinued |
0.6074 |
Remote Similarity |
NPD535 |
Approved |
0.6074 |
Remote Similarity |
NPD1120 |
Approved |
0.6074 |
Remote Similarity |
NPD1121 |
Approved |
0.6058 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.6027 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.6012 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.6011 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD5486 |
Discontinued |
0.598 |
Remote Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.598 |
Remote Similarity |
NPD34 |
Approved |
0.598 |
Remote Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.598 |
Remote Similarity |
NPD4714 |
Approved |
0.5975 |
Remote Similarity |
NPD515 |
Phase 1 |
0.5972 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.5952 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.5946 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.5934 |
Remote Similarity |
NPD9582 |
Phase 3 |
0.5924 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.592 |
Remote Similarity |
NPD5458 |
Discontinued |
0.5919 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.5918 |
Remote Similarity |
NPD691 |
Discontinued |
0.5891 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.5891 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.5891 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.5891 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.5882 |
Remote Similarity |
NPD9406 |
Approved |
0.5862 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.5849 |
Remote Similarity |
NPD9544 |
Approved |
0.5849 |
Remote Similarity |
NPD78 |
Approved |
0.5813 |
Remote Similarity |
NPD796 |
Phase 2 |
0.5806 |
Remote Similarity |
NPD8833 |
Approved |
0.5806 |
Remote Similarity |
NPD8831 |
Approved |
0.5802 |
Remote Similarity |
NPD6036 |
Suspended |
0.5779 |
Remote Similarity |
NPD757 |
Phase 3 |
0.5769 |
Remote Similarity |
NPD9360 |
Approved |
0.5735 |
Remote Similarity |
NPD534 |
Phase 2 |
0.5735 |
Remote Similarity |
NPD537 |
Phase 2 |
0.5734 |
Remote Similarity |
NPD5627 |
Approved |
0.5705 |
Remote Similarity |
NPD1368 |
Approved |
0.57 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.5679 |
Remote Similarity |
NPD1775 |
Approved |
0.5679 |
Remote Similarity |
NPD1085 |
Approved |
0.5676 |
Remote Similarity |
NPD3849 |
Clinical (unspecified phase) |
0.5669 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.5667 |
Remote Similarity |
NPD9291 |
Approved |
0.566 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.566 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.5659 |
Remote Similarity |
NPD5768 |
Phase 2 |
0.5642 |
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |
0.564 |
Remote Similarity |
NPD9704 |
Approved |
0.5619 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5614
|
Remote Similarity |
NPD6351 |
Discovery |